Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Volume 1866, Issue 1, 1 January 2020, 165561
RAD6B is a major mediator of triple negative breast cancer cisplatin resistance: Regulation of translesion synthesis/Fanconi anemia crosstalk and BRCA1 independence
Under an Elsevier user license
open archive
Keywords
Triple negative breast cancer
BRCA1
FANCD2
POL η
H2AX
Cisplatin
Ubiquitination
Small molecule inhibitor
Homologous recombination
Replication restart
Cited by (0)
© 2019 Elsevier B.V.